{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:46:42Z","timestamp":1789685202332,"version":"4.0.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Severe manifestations of systemic lupus erythematosus (SLE), antiphospholipid syndrome (APS), and thrombotic thrombocytopenic purpura (TTP) are characterized by multiorgan thrombotic microangiopathy. We describe reduction of ADAMTS13 activity and the development of systemic autoimmunity in all 8 children initially diagnosed with acquired noncongenital TTP during an 8.5-year period. Median age at diagnosis was 12.0 years (range, 2.6\u201317.3 years). ADAMTS13 activity was absent (&amp;lt;5%) in 6 patients; 3 patients had a detected inhibitor. SLE was diagnosed concurrently in 3 patients, and 4 patients were diagnosed within 5 years. Six of the children diagnosed with SLE had absent ADAMTS13 activity at diagnosis. In 6 patients with SLE, immune-mediated nephritis developed by 46 months. All surviving patients with SLE developed antiphospholipid antibodies, including some with a lupus anticoagulant. Patients with SLE did not have TTP recurrences once daily immunosuppressive regimens were started. An evaluation for SLE\/APS is warranted in children and adolescents with reduced ADAMTS13 activity and thrombotic microangiopathy.<\/jats:p>","DOI":"10.1309\/ajcp5bvl4fclcglu","type":"journal-article","created":{"date-parts":[[2011,2,24]],"date-time":"2011-02-24T18:37:47Z","timestamp":1298572667000},"page":"406-416","source":"Crossref","is-referenced-by-count":25,"title":["Thrombotic Microangiopathic Hemolytic Anemia With Reduction of ADAMTS13 Activity"],"prefix":"10.1093","volume":"135","author":[{"given":"Eyal","family":"Muscal","sequence":"first","affiliation":[{"name":"1Baylor College of Medicine and Pediatric Rheumatology Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel M.","family":"Edwards","sequence":"additional","affiliation":[{"name":"2Department of Pathology, Texas Children\u2019s Hospital, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra L.","family":"Kearney","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Immunology, Texas Children\u2019s Hospital and Baylor College of Medicine, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Hicks","sequence":"additional","affiliation":[{"name":"3Department of Pathology and Immunology, Texas Children\u2019s Hospital and Baylor College of Medicine, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry L.","family":"Myones","sequence":"additional","affiliation":[{"name":"1Baylor College of Medicine and Pediatric Rheumatology Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Teruya","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Immunology, Pediatrics, and Medicine, Texas Children\u2019s Hospital and Baylor College of Medicine, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,3,1]]},"reference":[{"key":"2023011909492683300_b1-1350406","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMra020528","article-title":"Thrombotic microangiopathies","volume":"347","author":"Moake","year":"2002","journal-title":"N Engl J Med"},{"key":"2023011909492683300_b2-1350406","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMcp053024","article-title":"Clinical practice: thrombotic thrombocytopenic purpura","volume":"354","author":"George","year":"2006","journal-title":"N Engl J Med"},{"key":"2023011909492683300_b3-1350406","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","article-title":"Changes in health and disease of the metalloprotease that cleaves von Willebrand factor","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"key":"2023011909492683300_b4-1350406","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1160\/TH05-11-0774","article-title":"Alteration of ADAMTS13 antigen levels in patients with idiopathic thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura and systemic lupus erythematosus [letter]","volume":"95","author":"Liu","year":"2006","journal-title":"Thromb Haemost"},{"key":"2023011909492683300_b5-1350406","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.seminhematol.2003.10.008","article-title":"von Willebrand factor\u2013cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience","volume":"41","author":"Hovinga","year":"2004","journal-title":"Semin Hematol"},{"key":"2023011909492683300_b6-1350406","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/01.md.0000133622.03370.07","article-title":"Severe ADAMTS13 deficiency in adult idiopathic thrombotic microangiopathies defines a subset of patients characterized by various autoimmune manifestations, lower platelet count, and mild renal involvement","volume":"83","author":"Coppo","year":"2004","journal-title":"Medicine (Baltimore)"},{"key":"2023011909492683300_b7-1350406","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/SMJ.0b013e318046583f","article-title":"Overlapping features of thrombotic thrombocytopenic purpura and systemic lupus erythematosus","volume":"100","author":"George","year":"2007","journal-title":"South Med J"},{"key":"2023011909492683300_b8-1350406","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/096120339900800613","article-title":"Relapsing catastrophic antiphospholipid antibody syndrome: a mimic for thrombotic thrombocytopenic purpura?","volume":"8","author":"Cerveny","year":"1999","journal-title":"Lupus"},{"key":"2023011909492683300_b9-1350406","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"2023011909492683300_b10-1350406","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2023011909492683300_b11-1350406","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2141.2009.07856.x","article-title":"Concurrent thrombotic thrombocytopenic purpura and antiphospholipid syndrome: a rare and severe clinical combination [letter]","volume":"147","author":"D\u00edaz-Cremades","year":"2009","journal-title":"Br J Haematol"},{"key":"2023011909492683300_b12-1350406","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0028-1082269","article-title":"Antiphospholipid antibodies and the antiphospholipid syndrome: clinical significance and treatment","volume":"34","author":"Asherson","year":"2008","journal-title":"Semin Thromb Hemost"},{"key":"2023011909492683300_b13-1350406","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood-2006-10-053199","article-title":"\u03b22-Glycoprotein I inhibits von Willebrand factor\u2013dependent platelet adhesion and aggregation","volume":"110","author":"Hulstein","year":"2007","journal-title":"Blood"},{"key":"2023011909492683300_b14-1350406","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"2023011909492683300_b15-1350406","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00043426-200304000-00016","article-title":"Case series of thrombotic thrombocytopenic purpura in children and adolescents","volume":"25","author":"Horton","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"2023011909492683300_b16-1350406","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-3476(05)80596-7","article-title":"Chronic relapsing thrombotic thrombocytopenic purpura in infants with large von Willebrand factor multimers during remission","volume":"120","author":"Chintagumpala","year":"1992","journal-title":"J Pediatr"},{"key":"2023011909492683300_b17-1350406","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1055\/s-2006-939764","article-title":"Thrombotic thrombocytopenic purpura associated with von Willebrand factor\u2013cleaving protease (ADAMTS13) deficiency in children","volume":"32","author":"Loirat","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"2023011909492683300_b18-1350406","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00467-008-0863-5","article-title":"Thrombotic thrombocytopenic purpura related to severe ADAMTS13 deficiency in children","volume":"24","author":"Loirat","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"2023011909492683300_b19-1350406","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/MBC.0b013e32833679cb","article-title":"Acquired, noncongenital thrombotic thrombocytopenic purpura in children and adolescents: clinical management and the use of ADAMTS 13 assays","volume":"21","author":"McDonald","year":"2010","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2023011909492683300_b20-1350406","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/1529-0131(199911)42:11<2346::AID-ANR13>3.0.CO;2-X","article-title":"Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood","volume":"42","author":"Brunner","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2023011909492683300_b21-1350406","first-page":"363","article-title":"Thrombotic thrombocytopenic purpura as a rare complication in childhood systemic lupus erythematosus: case report and literature review","volume":"9","author":"Chak","year":"2003","journal-title":"Hong Kong Med J"},{"key":"2023011909492683300_b22-1350406","first-page":"914","article-title":"von Willebrand factor cleaving protease (ADAMTS-13) in 123 patients with connective tissue diseases (systemic lupus erythematosus and systemic sclerosis)","volume":"88","author":"Mannucci","year":"2003","journal-title":"Haematologica"},{"key":"2023011909492683300_b23-1350406","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1002\/art.20551","article-title":"Thrombotic thrombocytopenic purpura with severe ADAMTS-13 deficiency in two patients with primary antiphospholipid syndrome","volume":"50","author":"Amoura","year":"2004","journal-title":"Arthritis Rheum"},{"key":"2023011909492683300_b24-1350406","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1365-2141.2008.07074.x","article-title":"The VWF\/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction","volume":"141","author":"Austin","year":"2008","journal-title":"Br J Haematol"},{"key":"2023011909492683300_b25-1350406","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2004-11-4490","article-title":"ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases","volume":"106","author":"Rieger","year":"2005","journal-title":"Blood"},{"key":"2023011909492683300_b26-1350406","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/rheumatology\/ken510","article-title":"A comparison of thrombotic thrombocytopenic purpura in an inception cohort of patients with and without systemic lupus erythematosus","volume":"48","author":"Letchumanan","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"2023011909492683300_b27-1350406","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/0961203308094360","article-title":"Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: risk factors and clinical outcome: a single centre study","volume":"18","author":"Kwok","year":"2009","journal-title":"Lupus"},{"key":"2023011909492683300_b28-1350406","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1056\/NEJM199811263392203","article-title":"Antibodies to von Willebrand factor\u2013cleaving protease in acute thrombotic thrombocytopenic purpura","volume":"339","author":"Tsai","year":"1998","journal-title":"N Engl J Med"},{"key":"2023011909492683300_b29-1350406","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/01.moh.0000169286.74464.3a","article-title":"Measurement of ADAMTS13 activity and inhibitors","volume":"12","author":"Miyata","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"2023011909492683300_b30-1350406","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1056\/NEJM199811263392202","article-title":"von Willebrand factor\u2013cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"N Engl J Med"},{"key":"2023011909492683300_b31-1350406","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/art.10561","article-title":"Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing","volume":"47","author":"Solomon","year":"2002","journal-title":"Arthritis Rheum"},{"key":"2023011909492683300_b32-1350406","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJM199805073381906","article-title":"Antibodies to DNA","volume":"338","author":"Hahn","year":"1998","journal-title":"N Engl J Med"},{"key":"2023011909492683300_b33-1350406","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1055\/s-0038-1649901","article-title":"Criteria for the diagnosis of lupus anticoagulants: an update: on behalf of the Subcommittee on Lupus Anticoagulant\/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH","volume":"74","author":"Brandt","year":"1995","journal-title":"Thromb Haemost"},{"key":"2023011909492683300_b34-1350406","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/rheumatology\/40.8.940","article-title":"Acquired deficiency of von Willebrand factor\u2013cleaving protease in a patient suffering from acute systemic lupus erythematosus","volume":"40","author":"Gungor","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"2023011909492683300_b35-1350406","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2177\/jsci.31.159","article-title":"Thrombotic thrombocytopenic purpura in patients with systemic lupus erythematosus [in Japanese]","volume":"31","author":"Miyamura","year":"2008","journal-title":"Nihon Rinsho Meneki Gakkai Kaishi"},{"key":"2023011909492683300_b36-1350406","doi-asserted-by":"crossref","first-page":"426","DOI":"10.3109\/s10165-007-0611-x","article-title":"Recurrent thrombotic thrombocytopenic purpura in a patient with systemic lupus erythematosus","volume":"17","author":"Maruoka","year":"2007","journal-title":"Mod Rheumatol"},{"key":"2023011909492683300_b37-1350406","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1182\/blood.V98.6.1842","article-title":"Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders","volume":"98","author":"Moore","year":"2001","journal-title":"Blood"},{"key":"2023011909492683300_b38-1350406","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0049-0172(98)80023-1","article-title":"Review of thrombotic thrombocytopenic purpura in the setting of systemic lupus erythematosus","volume":"28","author":"Musio","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"2023011909492683300_b39-1350406","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10067-003-0742-1","article-title":"Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: a case report and literature review","volume":"22","author":"Hamasaki","year":"2003","journal-title":"Clin Rheumatol"}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/135\/3\/406\/48769807\/ajcp_135_3_406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/135\/3\/406\/48769807\/ajcp_135_3_406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T11:32:26Z","timestamp":1674127946000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/135\/3\/406\/1766289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,1]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,1]]},"published-print":{"date-parts":[[2011,3,1]]}},"URL":"https:\/\/doi.org\/10.1309\/ajcp5bvl4fclcglu","relation":{},"ISSN":["1943-7722","0002-9173"],"issn-type":[{"value":"1943-7722","type":"electronic"},{"value":"0002-9173","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,3,1]]},"published":{"date-parts":[[2011,3,1]]}}}